Playlist


TCOR to launch specialized petrochemical unit to increase high-value export volumes
27 Jun. 11:54The primary manufacturing hub of the national oil and gas sector is positioned to deploy a new chemical production line. During a recent digital session of the Cabinet of Ministers, Vice-Premier G. Agajanov outlined an institutional strategy focused on diversifying the refining systems at the Turkmenbashi Complex of Oil Refineries (TCOR). The extensive engineering research for this upgrade is currently being managed by the "Turkmennebit" State Concern.
The technical development roadmap involves integrating automated software structures and advanced industrial hardware into the active infrastructure of the processing complex. The overarching goal of the initiative is to establish an agile manufacturing ecosystem capable of synthesizing advanced petrochemical compounds. This strategic deployment is structured to fulfill long-term economic blueprints prioritizing high-value resource optimization within the country.
From a trade perspective, the upcoming unit is designed to accelerate import substitution initiatives by replacing high-cost international chemical supplies with stable domestic alternatives. These new corporate product configurations are projected to display strong competitive metrics across regional markets and global commodity exchanges. The final legislative drafts and architectural outlines were formally presented to the head of state for executive approval.
After analyzing the industrial report, the President of Turkmenistan emphasized that the systematic optimization of domestic hydrocarbon processing lines remains a core economic priority. The Head of State formally approved the development blueprint for the new facility at the TCOR and directed the Vice-Premier to manage the technical execution of the project. The executive branch highlighted that maintaining strict compliance with modern environmental and safety thresholds is required throughout construction.
Also read


Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds
Today in 02:02Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.
Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.